Revvity unveils a new era of automated tuberculosis testing

May 3, 2024
New and improved workflow now available that pairs Revvity’s T-SPOT.TB test with the Auto-Pure 2400 liquid handling platform.

Revvity, Inc. announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test.

Auto-Pure 2400 liquid handler for use with the T-SPOT.TB test:

  • The Auto-Pure 2400 automated liquid handling platform is equipped with integrated magnetic cell isolation technology.
  • Designed for testing up to 24 samples per run, it completes day-1 T-SPOT.TB workflows in under 3.5 hours, requiring only a single mid-run user interaction.

About the T-SPOT.TB test:

  • The T-SPOT.TB test detects latent tuberculosis infection (LTBI) and is an interferon-gamma release assay (IGRA) based on the enzyme-linked immunospot (ELISPOT) technology.
  • Steps include washing, isolating, and counting peripheral blood mononuclear cells (PBMCs) before conducting the test.

Revvity release